Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
Authors:
- Katarina SteteKSKatarina Stete
- Stefanie J KrauthSKStefanie J Krauth
- Jean T CoulibalyJCJean T Coulibaly
- Stefanie KnoppSKStefanie Knopp
- Jan HattendorfJHJan Hattendorf
- Ivan MüllerIvan Müller
- Laurent K LohourignonLLLaurent K Lohourignon
- Winfried V KernWKWinfried V Kern
- Eliézer K N’gOranENEliézer K N’gOran
- Jürg UtzingerJUJürg Utzinger
Open Access
- 21 December 2012
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 5 (1) , 298
Abstract
Background: Praziquantel is the drug of choice in preventive chemotherapy targeting schistosomiasis. Increasing large-scale administration of praziquantel requires monitoring of drug efficacy to detect early signs of development of resistance. Standard protocols for drug efficacy monitoring are necessary. Here, we determined the optimal time point for praziquantel efficacy assessment against Schistosoma haematobium and studied the dynamics of infection parameters following treatment. Methods: Ninety school-aged children from south Côte d’Ivoire with a parasitologically confirmed S. haematobium infection were treated with a single oral dose of praziquantel (40 mg/kg) and followed up for 62 days post-treatment. Urine samples were collected on 23 schooldays during this period and were subjected to visual examination (macrohaematuria), urine filtration and microscopy (S. haematobium eggs) and reagent strip testing (microhaematuria, proteinuria and leukocyturia). Results: Observed cure and egg reduction rates were highly dependent on the time point post-treatment. Egg reduction rates were high (>97%) in weeks 3–9 post-treatment. Cure rates were highest in weeks 6 (92.9%) and 9 (95.0%) post-treatment. The prevalence of infection-associated parameters decreased after treatment, reaching a minimum of 2.4% in weeks 5 (proteinuria) and 7 (leukocyturia) post-treatment, and 16.3% at the end of week 8 (microhaematuria). Macrohaematuria disappeared between weeks 3 and 6 post-treatment. Conclusions: For monitoring praziquantel efficacy against S. haematobium, we recommend that the cure rate is assessed at week 6 post-treatment. The egg reduction rate can be evaluated earlier, from day 14 post-treatment onwards. Reagent strips are a useful additional tool for evaluating treatment outcomes in areas with high endemicity, preferably at weeks 5 and 6 post-treatment. The delayed decrease of microhaematuria confirms that lesions in the urinary tract persist longer than egg excretion post-treatment.Keywords
This publication has 53 references indexed in Scilit:
- Intestinal parasitic infections in schoolchildren in different settings of Côte d’Ivoire: effect of diagnostic approach and implications for controlParasites & Vectors, 2012
- Effect of Schistosomiasis and Soil-Transmitted Helminth Infections on Physical Fitness of School Children in Côte d'IvoirePLOS Neglected Tropical Diseases, 2011
- Questionnaire-based approach to assess schoolchildren's physical fitness and its potential role in exploring the putative impact of helminth and Plasmodium spp. infections in Côte d'IvoireParasites & Vectors, 2011
- Parasites and poverty: The case of schistosomiasisActa Tropica, 2010
- Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of cautionParasitology, 2009
- Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease BurdenPLOS Neglected Tropical Diseases, 2009
- The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in MozambiqueParasitology, 2009
- Control of Neglected Tropical DiseasesNew England Journal of Medicine, 2007
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and MalariaPLOS Medicine, 2006